Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250M
09 Feb 2022 //
BUSINESSWIRE
Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal
17 Dec 2020 //
BUSINESSWIRE
Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Antibodies
17 Dec 2020 //
BUSINESSWIRE
Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal
17 Dec 2020 //
BUSINESSWIRE
Ology Bioservices Awarded $37 Million by Department of Defense
23 Nov 2020 //
BUSINESSWIRE
Ology Bioservices Awarded US Army Contract to Manage Production of COVID-19
26 Aug 2020 //
PHARMATECH
Ology Bioservices to Adapt Veroplex® Cell Platform for Rapid Response
22 Apr 2020 //
BUSINESSWIRE